We have some important new information from the HVTN 505 vaccine study to share with you.
We are going to stop further injections in the HVTN 505 study because the vaccine did not show efficacy. This means it did not work to prevent HIV infection nor reduce the amount of virus (viral load) in the blood among people in the study who became infected with HIV. Participants enrolled in the study will be unblinded (find out whether they received a vaccine or placebo) in the upcoming few weeks, but study visits will continue.
The first order of business when we heard this news was to notify our study participants (prior to the release of the information to the public). At this time, all RVA HVTN 505 volunteers enrolled in Rochester and Buffalo have been contacted/informed of this important study update.
Although the news is not what we were hoping for, the ongoing support of our volunteers and our community will continue to allow us to better understand how to develop effective HIV vaccines. This news is extremely disappointing to our team, but the information we gain from this study is critical in planning the future direction of HIV vaccine research and we could not have learned this without your support.
Undoubtedly, there will be a lot of news about this study in the upcoming days and weeks. We are committed to providing accurate information to our volunteers and community partners at the earliest possible time. At this time we can provide you the press release sent out today by the National Institute of Health.
As additional information is released we will share this with you. If you have questions or comments about this study or HIV prevention in general, please don’t hesitate to contact us!
Thank you once again for your commitment to ending AIDS!
The entire Rochester Victory Alliance team